+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Myopia & Presbyopia Treatment Market Research Report by Treatment, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5012905
  • Report
  • June 2021
  • Region: Global
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Myopia & Presbyopia Treatment Market Grew USD 22,486.02 Million by 2025, at a CAGR of 7.13%

FEATURED COMPANIES

  • ABB Optical Group
  • Accu-Lens Inc.
  • Arctic Vision
  • CooperVision, Inc.
  • Eyenovia, Inc.
  • Johnson & Johnson Vision
  • MORE
The Global Myopia & Presbyopia Treatment Market size was estimated at USD 15,932.95 Million in 2020 and expected to reach USD 17,005.80 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.13% from 2020 to 2025 to reach USD 22,486.02 Million by 2025.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Myopia & Presbyopia Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment, the Myopia & Presbyopia Treatment Market was examined across Contact Lenses, Medication, Prescription Lenses, and Surgery.
  • Based on Indication, the Myopia & Presbyopia Treatment Market was examined across Myopia and Presbyopia.
  • Based on Geography, the Myopia & Presbyopia Treatment Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Myopia & Presbyopia Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Myopia & Presbyopia Treatment Market, including ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Myopia & Presbyopia Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Myopia & Presbyopia Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Myopia & Presbyopia Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Myopia & Presbyopia Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Myopia & Presbyopia Treatment Market?
6. What is the market share of the leading vendors in the Global Myopia & Presbyopia Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Myopia & Presbyopia Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ABB Optical Group
  • Accu-Lens Inc.
  • Arctic Vision
  • CooperVision, Inc.
  • Eyenovia, Inc.
  • Johnson & Johnson Vision
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Indication Outlook
3.4. Treatment Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Vision Impairment
5.1.1.2. Rising Geriatric Population
5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
5.1.2. Restraints
5.1.2.1. Lack of Early Diagnosis and Product Recalls
5.1.3. Opportunities
5.1.3.1. Increasing Market Amalgamation Activity
5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
5.1.4. Challenges
5.1.4.1. High Cost Associated with the Treatment
5.2. Cumulative Impact of COVID-19
5.3. Porters Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry

6. Myopia & Presbyopia Treatment Market, by Treatment
6.1. Introduction
6.2. Contact Lenses
6.3. Medication
6.4. Prescription Lenses
6.5. Surgery

7. Myopia & Presbyopia Treatment Market, by Indication
7.1. Introduction
7.2. Myopia
7.3. Presbyopia

8. Americas Myopia & Presbyopia Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Myopia & Presbyopia Treatment Market
9.1. Introduction
9.2. China
9.3. India
9.4. Indonesia
9.5. Japan
9.6. Malaysia
9.7. Philippines
9.8. South Korea
9.9. Thailand

10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. ABB Optical Group
12.2. AbbVie Inc.
12.3. Accu-Lens Inc.
12.4. Alcon Vision LLC
12.5. Arctic Vision
12.6. Bausch & Lomb Incorporated by Bausch Health Companies Inc.
12.7. Carl Zeiss AG
12.8. CooperVision, Inc.
12.9. Essilor Group
12.10. Euclid Systems Corporation
12.11. Eyenovia, Inc.
12.12. Haag-Streit Group
12.13. Johnson & Johnson Vision
12.14. Menicon Co., Ltd.
12.15. Nidek Co. Ltd.
12.16. Topcon Corporation
12.17. Tylock-George Eye Care & Laser Center
12.18. Ziemer Ophthalmic Systems AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
13.3. Contact Details

List of Tables
TABLE 1. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESCRIPTION LENSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: SCORES
TABLE 69. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: BUSINESS STRATEGY
TABLE 70. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 71. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: RANKING
TABLE 72. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: MERGER & ACQUISITION
TABLE 73. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 74. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 75. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 76. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 77. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: LICENSE & PRICING
TABLE 78. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET: CONTACT DETAILS
Note: Product cover images may vary from those shown
  • ABB Optical Group
  • AbbVie Inc.
  • Accu-Lens Inc.
  • Alcon Vision LLC
  • Arctic Vision
  • Bausch & Lomb Incorporated by Bausch Health Companies Inc.
  • Carl Zeiss AG
  • CooperVision, Inc.
  • Essilor Group
  • Euclid Systems Corporation
  • Eyenovia, Inc.
  • Haag-Streit Group
  • Johnson & Johnson Vision
  • Menicon Co., Ltd.
  • Nidek Co. Ltd.
  • Topcon Corporation
  • Tylock-George Eye Care & Laser Center
  • Ziemer Ophthalmic Systems AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll